A detailed history of Integris Wealth Management, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Integris Wealth Management, LLC holds 4,593 shares of ABBV stock, worth $888,975. This represents 0.23% of its overall portfolio holdings.

Number of Shares
4,593
Previous 4,639 0.99%
Holding current value
$888,975
Previous $845 Million 6.74%
% of portfolio
0.23%
Previous 0.23%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 19, 2024

SELL
$154.79 - $180.76 $7,120 - $8,314
-46 Reduced 0.99%
4,593 $788 Million
Q1 2024

May 03, 2024

BUY
$159.82 - $182.1 $32,443 - $36,966
203 Added 4.58%
4,639 $845 Million
Q4 2023

Feb 09, 2024

BUY
$137.6 - $154.97 $6,329 - $7,128
46 Added 1.05%
4,436 $687 Million
Q3 2023

Nov 08, 2023

BUY
$133.59 - $154.65 $17,099 - $19,795
128 Added 3.0%
4,390 $654 Million
Q4 2022

Feb 07, 2023

BUY
$138.31 - $165.87 $589,477 - $706,937
4,262 New
4,262 $689 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $342B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Integris Wealth Management, LLC Portfolio

Follow Integris Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Integris Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Integris Wealth Management, LLC with notifications on news.